Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
J Neurooncol. 2012 May;108(1):1-10. doi: 10.1007/s11060-011-0776-1. Epub 2011 Dec 16.

Medulloblasoma: challenges for effective immunotherapy.

Author information

  • 1Department of Neurological Surgery, Neurological Institute, New York Presbyterian Columbia University, New York, NY 10032, USA. adam.sonabend@gmail.com


For medulloblastoma patients, the current therapeutic paradigm of surgery followed by radiation and chemotherapy can lead to long-term remission. However, the sequelae of treatment can be very debilitating, particularly in young children. Immunotherapy is an attractive treatment approach to optimize the targeting of tumor cells while sparing the vulnerable surrounding brain that is still developing in children. Understanding the relationship between medulloblastoma and the immune system is critical to develop effective immunologic-based treatment strategies for these patients. This review focuses on current knowledge of tumor immunology and the factors that contribute to the lack of immune system recognition of these tumors. The specificity of tumor antigens present in medulloblastoma is also discussed along with a summary of early clinical immunotherapy results.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Springer
    Loading ...
    Write to the Help Desk